Arbutus Biopharma Corporation (I9DN)
Market Closed
7 Oct, 06:01
XMUN 
€
3. 63
-0.09
-2.32%
€
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-0.45 Eps
€ 3.71
Previous Close Day Range
3.63 3.63
Year Range
2.5 4.27
Want to track I9DN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 26 days
| ABUS Arbutus Biopharma Corporation 5 Nov 2025 (In 3 weeks) | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 5 Nov 2025 (In 3 weeks) | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 4 Nov 2025 (In 3 weeks) | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 7 Aug 2025 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 6 Aug 2025 | | - Cons. EPS | 0.01 EPS |
| ABUS Arbutus Biopharma Corporation 31 Jul 2025 | | - Cons. EPS | 0.01 EPS |
| ABUS Arbutus Biopharma Corporation 30 Apr 2025 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 26 Feb 2025 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 6 Nov 2024 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 5 Nov 2024 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 1 Aug 2024 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 2 May 2024 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 29 Feb 2024 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 7 Nov 2023 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 3 Nov 2016 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 4 Aug 2016 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 4 May 2016 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 9 Mar 2016 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 5 Nov 2015 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 7 Aug 2015 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 6 May 2015 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 12 Mar 2015 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 6 Nov 2014 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 13 Aug 2014 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 14 May 2014 | | 0.23 Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 6 Mar 2014 | | 0.05 Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 13 Nov 2013 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 12 Aug 2013 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 14 May 2013 | | - Cons. EPS | - EPS |
| ABUS Arbutus Biopharma Corporation 27 Mar 2013 | | - Cons. EPS | 2.7 EPS |
I9DN Earnings Reports FAQ
What is the earnings per share (EPS) for I9DN?
The current EPS is -0.45.
What is the company's earnings growth rate?
Arbutus Biopharma Corporation has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Arbutus Biopharma Corporation has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Arbutus Biopharma Corporation are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for I9DN at this time, as Arbutus Biopharma Corporation has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
